Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings

Publisher： Karger

E-ISSN： 1423-0356|70|5|500-506

ISSN： 0025-7931

Source： Respiration, Vol.70, Iss.5, 2003-12, pp. : 500-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Value of F-18 FDG PET/CT for Malignant Pleural Effusion in Non-Small Cell Lung Cancer Patients

By  

Oncology Research and Treatment, Vol. 34, Iss. 6, 2011-05 ,pp. : 298-303

Karger

Access to resources Recommend Favorite

FDG-PET: An Important Tool in the Diagnosis of Lung Cancer

By  

Oncology Research and Treatment, Vol. 30, Iss. 7, 2007-06 ,pp. : 352-352

Karger

Access to resources Recommend Favorite

Impact of FDG-PET-Induced Treatment Choices on Long-Term Outcome in Non-Small Cell Lung Cancer

By  

Respiration, Vol. 79, Iss. 2, 2009-05 ,pp. : 97-104

Karger

Access to resources Recommend Favorite

Mediastinal Lymph Node Staging in Potentially Resectable Non-Small Cell Lung Cancer: A Prospective Comparison of CT and EUS/EUS-FNA

By  

Respiration, Vol. 78, Iss. 4, 2009-08 ,pp. : 423-431

Karger

Access to resources Recommend Favorite

The Role of Integrated 18F-FDG PET-CT as a Staging Tool for Limited-Stage Small Cell Lung Cancer: A Retrospective Study

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 432-438

Karger

Access to resources Recommend Favorite